{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:01:51Z","timestamp":1781064111773,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,6]],"date-time":"2027-03-06T00:00:00Z","timestamp":1804291200000},"content-version":"am","delay-in-days":248,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD021616-01"],"award-info":[{"award-number":["1S10OD021616-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020940","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1F31NS118955-01A1"],"award-info":[{"award-number":["1F31NS118955-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbi.2026.106526","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:17:33Z","timestamp":1772583453000},"page":"106526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis"],"prefix":"10.1016","volume":"135","author":[{"given":"Michael","family":"Linzey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour-Maria","family":"Bouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine","family":"Scholand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia Gonzalez","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"DeCristofano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiep","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-458X","authenticated-orcid":false,"given":"Francesca","family":"Gilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106526_b0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2026.106526_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00601","article-title":"Progressive multiple sclerosis: evaluating current therapies and exploring future treatment strategies","volume":"22","author":"Albelo-Martinez","year":"2025","journal-title":"Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/j.bbi.2026.106526_b0015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1471-4159.2008.05668.x","article-title":"The complement cascade: Yin-Yang in neuroinflammation\u2013neuro-protection and -degeneration","volume":"107","author":"Alexander","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2026.106526_b0020","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106526_b0025","article-title":"Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments","volume":"2015","author":"Bonnan","year":"2015","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.bbi.2026.106526_b0030","first-page":"326","article-title":"Behavioral differences among fourteen inbred mouse strains commonly used as disease models","volume":"55","author":"Bothe","year":"2005","journal-title":"Comp. Med."},{"key":"10.1016\/j.bbi.2026.106526_b0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jnr.10721","article-title":"Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576","volume":"74","author":"Chauhan","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2026.106526_b0040","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2026.106526_b0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2016.00430","article-title":"Ectopic lymphoid structures: powerhouse of autoimmunity","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106526_b0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2026.106526_b0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12974-019-1501-9","article-title":"Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis","volume":"16","author":"DiSano","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106526_b0060","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3389\/fimmu.2019.01821","article-title":"Central nervous system inflammatory aggregates in the theiler's virus model of progressive multiple sclerosis","volume":"10","author":"DiSano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106526_b0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-017-0812-y","article-title":"Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study","volume":"14","author":"Farina","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106526_b0070","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2026.106526_b0075","doi-asserted-by":"crossref","unstructured":"Gasperi, C., Salmen, A., Antony, G., Bayas, A., Heesen, C., Kumpfel, T., Linker, R.A., Paul, F., Stangel, M., Tackenberg, B., Bergh, F.T., Warnke, C., Weber, F., Wiendl, H., Wildemann, B., Zettl, U.K., Ziemann, U., Zipp, F., Tumani, H., Gold, R., Hemmer, B., German Competence Network of Multiple, S., 2019. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. JAMA neurology 76, 841-849.","DOI":"10.1001\/jamaneurol.2019.0905"},{"key":"10.1016\/j.bbi.2026.106526_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbi.2026.106526_b0085","doi-asserted-by":"crossref","unstructured":"Gerhauser, I., Hansmann, F., Ciurkiewicz, M., Loscher, W., Beineke, A., 2019. Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update. International journal of molecular sciences 20.","DOI":"10.3390\/ijms20020448"},{"key":"10.1016\/j.bbi.2026.106526_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160071","article-title":"High-resolution diffusion tensor spinal cord MRI measures as biomarkers of disability progression in a rodent model of progressive multiple sclerosis","volume":"11","author":"Gilli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106526_b0095","doi-asserted-by":"crossref","DOI":"10.3791\/54616","article-title":"Measuring progressive neurological disability in a mouse model of multiple sclerosis","author":"Gilli","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbi.2026.106526_b0100","doi-asserted-by":"crossref","DOI":"10.3791\/60495","article-title":"Quantitative measurement of intrathecally synthesized proteins in mice","author":"Gilli","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbi.2026.106526_b0105","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.biomaterials.2011.12.017","article-title":"Target delivery of a gene into the brain using the RVG29-oligoarginine peptide","volume":"33","author":"Gong","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbi.2026.106526_b0110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbi.2020.03.004","article-title":"Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis","volume":"87","author":"Hammond","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106526_b0115","first-page":"11","article-title":"The CXCL13\/CXCR5 Immune axis in health and disease-implications for intrathecal B cell activities in neuroinflammation","author":"Harrer","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106526_b0120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbi.2026.106526_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2051-5960-2-53","article-title":"Complement activation in multiple sclerosis plaques: an immunohistochemical analysis","volume":"2","author":"Ingram","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbi.2026.106526_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2023.03.003","article-title":"Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma","volume":"259","author":"Ji","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbi.2026.106526_b0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/jnnp.2008.150896","article-title":"CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients","volume":"80","author":"Joseph","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106526_b0140","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbi.2026.106526_b0145","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4103\/1673-5374.194804","article-title":"Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response","volume":"11","author":"Koudriavtseva","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbi.2026.106526_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2026.106526_b0155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1091581817740873","article-title":"Nonclinical development of ANX005: a humanized Anti-C1q antibody for treatment of autoimmune and neurodegenerative diseases","volume":"36","author":"Lansita","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.bbi.2026.106526_b0160","doi-asserted-by":"crossref","unstructured":"Leitzen, E., Jin, W., Herder, V., Beineke, A., Elmarabet, S.A., Baumgartner, W., Hansmann, F., 2019. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease. International journal of molecular sciences 20.","DOI":"10.3390\/ijms20040989"},{"key":"10.1016\/j.bbi.2026.106526_b0165","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1096\/fj.11-201384","article-title":"Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging","volume":"26","author":"Li","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2026.106526_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115218","article-title":"TREM2: potential therapeutic targeting of microglia for Alzheimer's disease","volume":"165","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbi.2026.106526_b0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2026.106526_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.924734","article-title":"Divergent complement system activation in two clinically distinct murine models of multiple sclerosis","volume":"13","author":"Linzey","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106526_b0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2006.03205.x","article-title":"The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice","volume":"146","author":"Morgan","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbi.2026.106526_b0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ana.20486","article-title":"The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis","volume":"57","author":"Narayan","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2026.106526_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1396520","article-title":"The complement system in neurodegenerative and inflammatory diseases of the central nervous system","volume":"15","author":"Negro-Demontel","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbi.2026.106526_b0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clineuro.2017.05.026","article-title":"Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: clinical and MRI results","volume":"160","author":"Ozakbas","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbi.2026.106526_b0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2010.09.026","article-title":"Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis","volume":"232","author":"Pachner","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2026.106526_b0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2007.01.017","article-title":"Intrathecal antibody production in an animal model of multiple sclerosis","volume":"185","author":"Pachner","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2026.106526_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1019799","article-title":"Theiler's virus-induced demyelinating disease as an infectious model of progressive multiple sclerosis","volume":"15","author":"Pike","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2026.106526_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109523","article-title":"CXCL10(+) peripheral activation niches couple preferred sites of Th1 entry with optimal APC encounter","volume":"36","author":"Prizant","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2026.106526_b0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fncel.2014.00344","article-title":"Nanobodies as modulators of inflammation: potential applications for acute brain injury","volume":"8","author":"Rissiek","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2026.106526_b0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1096\/fba.2021-00161","article-title":"FVB\/N mouse strain regulatory T cells differ in phenotype and function from the C57BL\/6 and BALB\/C strains","volume":"4","author":"Tanner","year":"2022","journal-title":"FASEB Bioadv."},{"key":"10.1016\/j.bbi.2026.106526_b0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12974-016-0611-x","article-title":"Complement is activated in progressive multiple sclerosis cortical grey matter lesions","volume":"13","author":"Watkins","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106526_b0240","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s40120-023-00532-2","article-title":"Treatment patterns and unmet need for patients with progressive multiple sclerosis in the united states: survey results from 2016 to 2021","volume":"12","author":"Watson","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.bbi.2026.106526_b0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","article-title":"Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease","volume":"52","author":"Werneburg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2026.106526_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109646","article-title":"Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation","volume":"237","author":"Wu","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2026.106526_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102636","article-title":"The activation of microglia by the complement system in neurodegenerative diseases","volume":"104","author":"Zhao","year":"2025","journal-title":"Ageing Res. Rev."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:27:50Z","timestamp":1781062070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126002746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0889159126002746"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106526","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106526"}}